
Accelerating Breakthrough Innovation
Our commitment to advancing health and life sciences is reflected in our two specialised investment funds.
The 3xP Global Health Innovation Fund, combining private equity and venture capital, invests in capacity building to drive innovation efficiently across the value chain, from discovery to development and production.
Meanwhile, the 3xP Global SIF Innovation Fund is dedicated to supporting breakthroughs in medical care, with a focus on cutting-edge therapies and innovations shaping the future of healthcare.
Our Commitment to Health and Life Sciences
The SIF Innovation Fund invests in cutting-edge companies excelling in technology, mainly in health and life sciences. Guided by the UN Principles for Responsible Investment (UN PRI), we focus on sectors like Biotechnology, Artificial Intelligence, Blockchain, and Nanotechnology.
Our main goal is to support innovations that drive positive change and contribute to the UN Sustainable Development Goals (UN SDGs), regarding Goold Health and Well Being. Committed to integrating R&D with robust ESG practices, we promote a circular economy while delivering long-term value and resilience.
Our Health Innovation Fund is focused on shaping the future of healthcare by leveraging opportunities within Portugal’s thriving CDMO market, a cornerstone of the biopharma industry driven by increasing demand for specialised capabilities in biologics and advanced therapies.
We are targeting high-growth opportunities in healthcare and biotech, fostering synergies across our portfolio to drive innovation in digital health, AI-driven drug discovery, and early-stage healthspan-focused therapeutics.
O Health Innovation, Fundo de Capital de Risco Fechado é co-financiado em 60% pelo Fundo de Capitalização e Resiliência (FdCR), gerido pelo Banco Português de Fomento, no âmbito do Programa Consolidar.
Saiba mais em bpfomento.pt/pt/prr/ e recuperarportugal.gov.pt.

Portugal’s Prime Position for Healthcare Innovation
Capitalize on Portugal’s thriving Contract Development and Manufacturing Organisation (CMDO) sector, offering high-quality pharmaceutical services at competitive costs.
Diversified Investment Strategy Driving Healthspan
Take advantage of a comprehensive investment strategy that balances risk and maximises growth opportunities across healthtech and biotech, with a focus on promoting healthy aging.